VIROLOGICAL ANALYSIS OF PATIENTS RECEIVING TELAPREVIR ADMINISTERED Q8H OR Q12H WITH PEGINTERFERON-ALFA-2A OR -ALFA-2B AND RIBAVIRIN IN TREATMENT-NAiVE PATIENTS WITH GENOTYPE 1 HEPATITIS C: STUDY C208

被引：0
|
作者：
Marcellin, Patrick [1 ]
Forns, Xavier [2 ]
Goeser, Tobias [3 ]
Ferenci, Peter [4 ]
Nevens, Frederik [5 ]
Carosi, Giampiero [6 ]
Drenth, Joost P. [7 ]
De Backer, Koen [8 ]
van Heeswijk, Rudolf [8 ]
Luo, Donghan [9 ]
Picchio, Gaston [9 ]
Beumont-Mauviel, Maria [8 ]
机构：
[1] Hop Beaujon, Liver Unit, Clichy, France
[2] Univ Barcelona, Barcelona, Spain
[3] Klinikum Univ Koln, Cologne, Germany
[4] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria
[5] Univ Hosp Gasthuisberg, Dept Hepatol, B-3000 Leuven, Belgium
[6] Univ Brescia, Clin Infect & Trop Dis, Brescia, Italy
[7] Radboud Univ Nijmegen, Ctr Med, NL-6525 ED Nijmegen, Netherlands
[8] Tibotec BVBA, Mechelen, Belgium
[9] Tibotec Inc, Yardley, PA USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
194
引用
收藏
页码：395A / 395A
页数：1
相关论文
共 50 条
  • [21] ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: FINAL RESULTS OF STUDY C209
    Foster, G. R.
    Hezode, C.
    Bronowicki, J. -P.
    Carosi, G.
    Weiland, O.
    Verlinden, L.
    van Heeswijk, R.
    Van Baelen, B.
    Picchio, G.
    Beaumont-Mauviel, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S27 - S27
  • [22] ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209
    Foster, G. R.
    Hezode, C.
    Bronowicki, J. -P.
    Carosi, G.
    Weiland, O.
    Verlinden, L.
    van Heeswijk, R.
    Vangeneugden, T.
    Picchio, G.
    Beumont-Mauviel, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S22 - S22
  • [23] EFFICACY AND SAFETY OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN TREATMENT NAIVE PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1
    Sulkowski, Mark S.
    Zeuzem, Stefan
    Lawitz, Eric
    Grigorescu, Mircea
    Tice, Alan D.
    Rustgi, Vinod K.
    Rodriguez-Torres, Maribel
    Lurie, Yoav
    Cianciara, Janusz
    Bacon, Bruce R.
    Bain, Vincent G.
    Kryczka, Wieslaw
    Pulkstenis, Erik
    Subramanian, G. M.
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (04) : 333A - 333A
  • [24] Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C
    Poynard, T
    Ratziu, V
    McHutchison, J
    Manns, M
    Goodman, Z
    Zeuzem, S
    Younossi, Z
    Albrecht, J
    HEPATOLOGY, 2003, 38 (01) : 75 - 85
  • [25] Boceprevir Plus Peginterferon Alfa-2B and Ribavirin in Russian Patients With Hepatitis C Virus Genotype 1 Infection: Treatment Week 8 Interim Analysis
    Isakov, Vasily
    Nikitin, Igor
    Chulanov, Vladimir P.
    Ogurtsov, Pavel P.
    Lukyanova, Ekaterina
    Long, Jianmin
    Wahl, Janice
    Helmond, Frans A.
    HEPATOLOGY, 2013, 58 : 1140A - 1140A
  • [26] Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C - Relapsed and treatment-naive patients
    Maddrey, WC
    SEMINARS IN LIVER DISEASE, 1999, 19 : 67 - 75
  • [27] Interferon alfa-2b and ribavirin in treatment-naive patients with chronic hepatitis C and normal ALT levels.
    Jacobson, I
    Lebovics, E
    Tobias, H
    Geders, J
    Klion, F
    Esposito, S
    HEPATOLOGY, 1999, 30 (04) : 459A - 459A
  • [28] A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS
    McHutchison, John G.
    Shiffman, Mitchell L.
    Terrault, Norah
    Manns, Michael P.
    Di Bisceglie, Adrian M.
    Jacobson, Ira M.
    Afdhal, Nezom H.
    Heathcote, E. Jenny
    Zeuzem, Stefan
    Reesink, Hendrik W.
    George, Shelley
    Adda, Nathalie
    Muir, Andrew J.
    HEPATOLOGY, 2008, 48 (04) : 431A - 432A
  • [29] Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
    Brixner, Diana I.
    Ye, Xin
    Chu, Teng-Chiao
    Blumentals, William A.
    Hassanein, Tarek I.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (24) : 2171 - 2178
  • [30] Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study
    Iacobellis, Angelo
    Siciliano, Massimo
    Perri, Francesco
    Annicchiarico, Brigida E.
    Leandro, Gioacchino
    Caruso, Nazario
    Accadia, Laura
    Bombardieri, Giuseppe
    Andriulli, Angelo
    JOURNAL OF HEPATOLOGY, 2007, 46 (02) : 206 - 212
12345